126 related articles for article (PubMed ID: 9369398)
1. Laryngofissure and cordectomy for glottic carcinoma limited to the mid third of the mobile true vocal cord.
Muscatello L; Laccourreye O; Biacabe B; Hans S; Ménard M; Brasnu D
Laryngoscope; 1997 Nov; 107(11 Pt 1):1507-10. PubMed ID: 9369398
[TBL] [Abstract][Full Text] [Related]
2. Cricohyoidoepiglottopexy for glottic carcinoma with fixation or impaired motion of the true vocal cord: 5-year oncologic results with 112 patients.
Chevalier D; Laccourreye O; Brasnu D; Laccourreye H; Piquet JJ
Ann Otol Rhinol Laryngol; 1997 May; 106(5):364-9. PubMed ID: 9153099
[TBL] [Abstract][Full Text] [Related]
3. Indications and results of cordectomy for early glottic carcinoma.
Olsen KD; Thomas JV; DeSanto LW; Suman VJ
Otolaryngol Head Neck Surg; 1993 Mar; 108(3):277-82. PubMed ID: 8464642
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin-fluorouracil exclusive chemotherapy for T1-T3N0 glottic squamous cell carcinoma complete clinical responders: five-year results.
Laccourreye O; Brasnu D; Bassot V; Ménard M; Khayat D; Laccourreye H
J Clin Oncol; 1996 Aug; 14(8):2331-6. PubMed ID: 8708725
[TBL] [Abstract][Full Text] [Related]
5. Type III thyroplasty for the treatment of glottic gap in a patient undergoing laryngofissure cordectomy for squamous cell carcinoma of the vocal fold: technique and outcome.
Kandogan T
Ear Nose Throat J; 2010 Jun; 89(6):272-5. PubMed ID: 20556739
[TBL] [Abstract][Full Text] [Related]
6. Radiotherapy with 6-megavolt photons for early glottic carcinoma: potential impact of extension to the posterior vocal cord.
Lee JH; Machtay M; McKenna MG; Weinstein GS; Markiewicz DA; Krisch RE; Kligerman MM
Am J Otolaryngol; 2001; 22(1):43-54. PubMed ID: 11172214
[TBL] [Abstract][Full Text] [Related]
7. Laryngofissure and cordectomy for early cordal carcinoma: outcome in 182 patients.
Neel HB; Devine KD; Desanto LW
Otolaryngol Head Neck Surg (1979); 1980; 88(1):79-84. PubMed ID: 7393605
[TBL] [Abstract][Full Text] [Related]
8. Analysis of local recurrence in patients with selected T1-3N0M0 squamous cell carcinoma of the true vocal cord managed with a platinum-based chemotherapy-alone regimen for cure.
Laccourreye O; Veivers D; Bassot V; Ménard M; Brasnu D; Laccourreye H
Ann Otol Rhinol Laryngol; 2002 Apr; 111(4):315-21; discussion 321-2. PubMed ID: 11991582
[TBL] [Abstract][Full Text] [Related]
9. Frontolateral vertical partial laryngectomy without tracheotomy for invasive squamous cell carcinoma of the true vocal cord: a 25-year experience.
Brumund KT; Gutierrez-Fonseca R; Garcia D; Babin E; Hans S; Laccourreye O
Ann Otol Rhinol Laryngol; 2005 Apr; 114(4):314-22. PubMed ID: 15895788
[TBL] [Abstract][Full Text] [Related]
10. Surgical therapy of T1 and selected cases of T2 glottic carcinoma: cordectomy, horizontal glottectomy and CO2 laser endoscopic resection.
Puxeddu R; Argiolas F; Bielamowicz S; Satta M; Ledda GP; Puxeddu P
Tumori; 2000; 86(4):277-82. PubMed ID: 11016703
[TBL] [Abstract][Full Text] [Related]
11. Cost-minimisation and cost-effectiveness analysis comparing transoral CO₂ laser cordectomy, laryngofissure cordectomy and radiotherapy for the treatment of T1-2, N0, M0 glottic carcinoma.
Diaz-de-Cerio P; Preciado J; Santaolalla F; Sanchez-Del-Rey A
Eur Arch Otorhinolaryngol; 2013 Mar; 270(4):1181-8. PubMed ID: 22872061
[TBL] [Abstract][Full Text] [Related]
12. [Recurrence after removal of a vocal cord for laryngeal fissure].
Herranz J; Vázquez Barro C; Suárez T; Fernández Fernández M; Martínez Vidal J
Acta Otorrinolaringol Esp; 1999; 50(8):619-22. PubMed ID: 10619897
[TBL] [Abstract][Full Text] [Related]
13. Oncologic outcomes of patients with positive margins after laser cordectomy for T1 and T2 glottic squamous cell carcinoma.
Charbonnier Q; Thisse AS; Sleghem L; Mouawad F; Chevalier D; Page C; Mortuaire G
Head Neck; 2016 Dec; 38(12):1804-1809. PubMed ID: 27248845
[TBL] [Abstract][Full Text] [Related]
14. Our experience in the surgical treatment of T1 carcinoma of the vocal cord.
Daniilidis J; Nikolaou A; Symeonidis V
J Laryngol Otol; 1990 Mar; 104(3):222-4. PubMed ID: 2341778
[TBL] [Abstract][Full Text] [Related]
15. A clinical trial of continuous cisplatin-fluorouracil induction chemotherapy and supracricoid partial laryngectomy for glottic carcinoma classified as T2.
Laccourreye O; Weinstein G; Brasnu D; Bassot V; Cauchois R; Jouffre V; Garcia D; Laccourreye H
Cancer; 1994 Nov; 74(10):2781-90. PubMed ID: 7954237
[TBL] [Abstract][Full Text] [Related]
16. Acoustic analysis of voice quality with or without false vocal fold displacement after cordectomy.
Bertino G; Bellomo A; Ferrero FE; Ferlito A
J Voice; 2001 Mar; 15(1):131-40. PubMed ID: 12269628
[TBL] [Abstract][Full Text] [Related]
17. Oncological and functional results of CO2 laser cordectomy.
Policarpo M; Aluffi P; Brovelli F; Borello G; Pia F
Acta Otorhinolaryngol Ital; 2004 Oct; 24(5):267-74. PubMed ID: 15871607
[TBL] [Abstract][Full Text] [Related]
18. T1-T2-T3 glottic tumors: fifteen years experience with CO2 laser.
Motta G; Esposito E; Cassiano B; Motta S
Acta Otolaryngol Suppl; 1997; 527():155-9. PubMed ID: 9197509
[TBL] [Abstract][Full Text] [Related]
19. Voice outcomes from subligamentous cordectomy for early glottic cancer.
Hillel AT; Johns MM; Hapner ER; Shah M; Wise JC; Klein AM
Ann Otol Rhinol Laryngol; 2013 Mar; 122(3):190-6. PubMed ID: 23577572
[TBL] [Abstract][Full Text] [Related]
20. Radiological tumor thickness as a risk factor for local recurrence in early glottic cancer treated with laser cordectomy.
Son HJ; Lee YS; Ku JY; Roh JL; Choi SH; Nam SY; Kim SY
Eur Arch Otorhinolaryngol; 2018 Jan; 275(1):153-160. PubMed ID: 29098372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
